FDA officials on Monday cautioned against altering the two-dose schedules for the two authorized COVID-19 vaccines. To reach more people faster, some have suggested stretching the time between the … Read More
Symptomatic people who have negative results from SARS-CoV-2 antigen tests should consider getting confirmation with a PCR test, as should asymptomatic people who have a positive antigen test, according … Read More
The U.S. coronavirus vaccine team is in discussions with Moderna and the FDA about whether to allow people to receive two doses of that vaccine at half the strength, … Read More
Among symptomatic nursing home residents with COVID-19, independent risk factors for all-cause mortality at 30 days include male sex, older age, and impaired cognition and physical function, according to … Read More
The CDC says the two mRNA COVID-19 vaccines authorized in the U.S. are contraindicated in people with a history of the following: severe allergic reaction after prior receipt of … Read More
NEJM, EDITORIAL Mariana C. Castells, M.D., Ph.D., and Elizabeth J. Phillips, M.D. In the world of Covid-19 and vaccines, many questions remain. What are the correlates of protective immunity after … Read More
LR Baden, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. The New England Journal of Medicine. DOI: 10.1056/NEJMoa2035389. The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing … Read More
Lancet Digit Health 2020 In this multicentre cohort study following more than 1·3 million patients with hypertension from the USA and Spain, we observed no clear association of increased … Read More
https://www.ema.europa.eu/documents/overview/comirnaty-epar-medicine-overview_en.pdf https://www.ema.europa.eu/documents/rmp/comirnaty-epar-risk-management-plan_en.pdf
The Lancet A study in The Lancet Respiratory Medicine details the high morbidity and mortality burden with COVID-19 relative to seasonal influenza. Researchers studied nearly 46,000 patients who were hospitalized with … Read More
